| |
 |
|
Class Information
Number: 514/317
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing
Description: Subject matter which contains an additional ring.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6022877 |
Use of (+)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl)ethyl]-4-piperidin emethanol in treating depressive disorders and bipolar disorders |
Feb. 8, 2000 |
| 6020347 |
4-substituted-4-piperidine carboxamide derivatives |
Feb. 1, 2000 |
| 6017931 |
Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
Jan. 25, 2000 |
| 6015789 |
Combined use of GnRH agonist and antagonist |
Jan. 18, 2000 |
| 6013656 |
2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors |
Jan. 11, 2000 |
| 6011046 |
Quinone compound, its production and use as antioxidant |
Jan. 4, 2000 |
| 6004980 |
(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2- (4-fluorophenyl)ethyl]-4-piperidinemethanol |
Dec. 21, 1999 |
| 6001881 |
Ortho-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament comprising them |
Dec. 14, 1999 |
| 6001854 |
Pharmaceutical for treating of neurological and neuropsychiatric disorders |
Dec. 14, 1999 |
| 5994369 |
Substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
Nov. 30, 1999 |
| 5994356 |
Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production |
Nov. 30, 1999 |
| 5990127 |
Process for the preparation of 4-(4-(4-(hydroxybiphenyl)-1-piperidinyl)-1-hydroxybutyl)-.alpha.,.alpha. -dimethylphenylacetic acid and phosphorylated derivatives |
Nov. 23, 1999 |
| 5985933 |
Methods for treating central and peripheral nerve pain |
Nov. 16, 1999 |
| 5985895 |
2-naphthamide derivatives and their therapeutic applications |
Nov. 16, 1999 |
| 5972941 |
Fungicidal mixtures of an oxime ether carboxylic acid amide with a morpholine or piperidine derivative |
Oct. 26, 1999 |
| 5968957 |
Method of using neurotrophic sulfonamide compounds |
Oct. 19, 1999 |
| 5965573 |
Compositions and methods for treating bone deficit conditions |
Oct. 12, 1999 |
| 5962507 |
O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds, and their use, as well as a method of preparing them |
Oct. 5, 1999 |
| 5962472 |
Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives |
Oct. 5, 1999 |
| 5958919 |
Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration |
Sep. 28, 1999 |
| 5952354 |
Tris carbamic acid esters: inhibitors of cholesterol absorption |
Sep. 14, 1999 |
| 5948780 |
Method for treating and preventing heart failure and ventricular dilatation |
Sep. 7, 1999 |
| 5948792 |
Fluorine-containing 1,4-disubstituted piperidine derivatives |
Sep. 7, 1999 |
| 5942548 |
Use of ethynyl alanine amino diol compounds for treatment of hypertension |
Aug. 24, 1999 |
| 5939425 |
Method for treating a migraine |
Aug. 17, 1999 |
| 5939411 |
Piperidine derivatives process for obtaining them and pharmaceutical compositions containing them |
Aug. 17, 1999 |
| 5935980 |
Use of pyrrolidine derivatives in the treatment of alcoholism |
Aug. 10, 1999 |
| 5932567 |
Thrombin inhibitors |
Aug. 3, 1999 |
| 5932196 |
Buffered emulsion compositions containing actives subject to acid or base hydrolysis |
Aug. 3, 1999 |
| 5932595 |
Matrix metalloprotease inhibitors |
Aug. 3, 1999 |
| 5932594 |
Muscarinic receptor antagonists |
Aug. 3, 1999 |
| 5929088 |
Cyclic amino acids as pharmaceutical agents |
Jul. 27, 1999 |
| 5925631 |
Alkylated styrenes as prodrugs to COX-2 inhibitors |
Jul. 20, 1999 |
| 5925646 |
Heterocyclic aryl-, alkyl- and cycloalkylacetamides |
Jul. 20, 1999 |
| 5922736 |
Chronic, bolus administration of D-threo methylphenidate |
Jul. 13, 1999 |
| 5919802 |
Methods of preventing and/or treating temporal lobe epilepsy |
Jul. 6, 1999 |
| 5905072 |
Adjuvants for systemic fungicides, fungicidal compositions which contain them and their use |
May. 18, 1999 |
| 5889024 |
Substituted heterocycles |
Mar. 30, 1999 |
| 5883108 |
Combination therapy for treating glaucoma |
Mar. 16, 1999 |
| 5880136 |
Sulfonamide fibrinogen receptor antagonists |
Mar. 9, 1999 |
| 5880132 |
Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception |
Mar. 9, 1999 |
| 5874447 |
4-Phenylpiperidine compounds for treating depression |
Feb. 23, 1999 |
| 5874445 |
(+) -.alpha.- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
Feb. 23, 1999 |
| 5874436 |
Triphenylalkyl antimicrobial agents |
Feb. 23, 1999 |
| 5872115 |
2-ureido-benzamide derivatives |
Feb. 16, 1999 |
| 5869067 |
Bi-aromatic compounds and pharmaceutical and cosmetic compositions |
Feb. 9, 1999 |
| 5863903 |
Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes |
Jan. 26, 1999 |
| 5863912 |
Method of treatment of hormone-unresponsive metastiatic prostate cancer |
Jan. 26, 1999 |
| 5863914 |
N,N-di(aryl) cyclic urea derivatives as anti-coagulants |
Jan. 26, 1999 |
| 5854268 |
Azetidine, pyrrolidine and piperidine derivatives |
Dec. 29, 1998 |
|
|
|
